Johns Hopkins School of Medicine/General Clinical Research Center
Baltimore, Maryland, 21205, United States
NCT Number: NCT00201110
The purpose of this study is to test a measurement tool and a new training intervention for problem solving in self-management of high cardiovascular disease (CVD) risk in African Americans with type 2 diabetes.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Baltimore, Maryland, 21205, United States
BACKGROUND:
African Americans with type 2 diabetes carry a high burden of CVD risk and adverse vascular events such as stroke and peripheral vascular disease. CVD risk factors of suboptimal blood pressure, lipids, and glycemic control are controllable through medical management and lifestyle behavior modification. The traditional primary care medical management model for these chronic CVD risks is inadequate, and models are shifting toward increased disease-related decision-making and self-management on the part of the patient. Yet, precise methods for: 1) identifying patients with ineffective disease-related problem-solving skills, and 2) providing patients with disease-related education that incorporates problem-solving and decision-making skills, have yet to be determined
DESIGN NARRATIVE:
The study will test a measurement tool and a novel training intervention for problem solving as applied to self-management of high CVD risk in African Americans with type 2 diabetes. The specific aims are to: 1) assess the validity and reliability of an empirically derived assessment tool of effective versus ineffective CVD risk-related problem-solving ability (the Health Problem Solving Scale, HPSS), 2) develop a novel intervention to teach CVD risk-related problem-solving skills to ineffective problem solvers, and 3) conduct a pilot study with a sample of African Americans with type 2 diabetes who have a high CVD risk profile (suboptimal blood pressure, lipids, and/or HbA1c) AND ineffective CVD risk-related problem-solving skills, as measured by the HPSS. The principal investigator is the recipient of a Research Scientist Development Award. Her career goal is to become an independent researcher in self-management of CVD risk in high-risk African American populations, and to be a leader in the development and translation into practice of novel, theory-driven and empirically based interventions to improve patient self-management of CVD risks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intensive Intervention: CVD Risk Self-Management Education (1 session) + Intensive Health Problem-Solving Training (8 sessions)
Time frame: Baseline, 3-month post-intervention follow-up
Time frame: Baseline, 1-week post-intervention follow-up, 3-month post-intervention follow-up
Time frame: Baseline, 3-month post-intervention follow-up
Time frame: Baseline, 3-month post-intervention follow-up
Time frame: baseline, 1-week post-intervention follow-up, 3-month post-intervention follow-up
Time frame: Baseline, 1-week post-intervention follow-up, 3-month post-intervention follow-up
Time frame: Baseline, 3-month post-intervention follow-up
Time frame: Baseline, 3-month post-intervention follow-up
Johns Hopkins University
Other
Problem Solving & CVD Risk Management in Diabetic Blacks
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00005487
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00041405
Cardiovascular Diseases, Coronary Disease
View Trial DetailsNCT00035711
Body Weight, Brain Diseases
View Trial DetailsNCT00005205
Angina Pectoris, Brain Diseases
View Trial Details